Patents by Inventor Kelvin Gee

Kelvin Gee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060293329
    Abstract: The present invention is related substituted enaminones represented by a compound of Formula I that are novel allosteric modulators of ?7 nAChRs. The invention also discloses the treatment of disorders that are responsive to enhancement of acetylcholine action on ?7 nAChRs in a mammal by administering an effective amount of a compound of Formula I.
    Type: Application
    Filed: June 15, 2006
    Publication date: December 28, 2006
    Inventors: Derk Hogenkamp, Timothy Johnstone, Kelvin Gee
  • Publication number: 20060178516
    Abstract: Substituted quinolone carboxylic acids and their derivatives are described. These compounds modulate the effect of ?-aminobutyric acid (GABA) via a novel site on the GABAA receptor complex in a therapeutically relevant fashion and may be used to ameliorate CNS disorders amenable to modulation of the GABAA receptor complex.
    Type: Application
    Filed: May 12, 2003
    Publication date: August 10, 2006
    Inventors: Timothy Johnstone, Derk Hogenkamp, Kelvin Gee
  • Patent number: 6875759
    Abstract: A method for the treatment of cancer and pain in an animal subject is disclosed, comprising administering to said animal in need of such treatment an effective amount of a compound of formula I: wherein R1-R6 are defined herein. Pharmaceutical compositions comprising one or more compounds of formula I and a pharmaceutically acceptable carrier are also disclosed.
    Type: Grant
    Filed: July 21, 2000
    Date of Patent: April 5, 2005
    Assignee: Kadmus Pharmaceuticals
    Inventors: Andrzej W. Lipkowski, Kelvin Gee